Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

130.43 

-1.65 -1.3%

as of Dec 18 '18

52 Week Range:

116.77 163.94


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 2.34
3.50
3.76
4.95
6.22
8.59
9.60
11.52
13.16
15.18
18.58
growth rate 49.6% 7.4% 31.7% 25.7% 38.1% 11.8% 20.0% 14.2% 15.4% 22.4%
Earnings BIT -3.47
12.82
18.11
23.10
32.88
34.88
2.23
1.00
-4.10
26.60
89.30
growth rate 100.0% 41.3% 27.6% 42.3% 6.1% -93.6% -55.2% -100.0% 100.0% 235.7%
Avg.PE -67.50
45.25
169.49
113.64
92.59
144.93
2,000.00
4,270.00
323.76
219.00
184.98
growth rate 100.0% 274.6% -33.0% -18.5% 56.5% 1,280.0% 113.5% -92.4% -32.4% -15.5%
ROA -4.88
21.70
4.97
5.38
6.25
4.82
0.42
-0.36
1.37
1.82
4.21
growth rate 100.0% -77.1% 8.3% 16.2% -22.9% -91.3% -100.0% 100.0% 32.9% 131.3%
ROE -62.29
30.15
7.63
8.52
9.35
6.84
0.74
-0.72
2.75
3.57
7.45
growth rate 100.0% -74.7% 11.7% 9.7% -26.8% -89.2% -100.0% 100.0% 29.8% 108.7%
ROIC -6.19
27.28
6.92
8.13
9.33
6.84
1.02
0.11
2.40
3.05
5.84
growth rate 100.0% -74.6% 17.5% 14.8% -26.7% -85.1% -89.2% 2,081.8% 27.1% 91.5%
Cur. Ratio 5.23
4.16
3.37
4.03
3.07
4.10
1.19
1.26
1.65
1.73
1.84
growth rate -20.5% -19.0% 19.6% -23.8% 33.6% -71.0% 5.9% 31.0% 4.9% 6.4%
Quick Ratio 5.07
3.75
3.10
3.77
2.84
3.82
1.02
1.15
1.56
1.61
1.67
growth rate -26.0% -17.3% 21.6% -24.7% 34.5% -73.3% 12.8% 35.7% 3.2% 3.7%
Leverage 1.37
1.40
1.66
1.53
1.48
1.37
2.04
1.96
2.06
1.88
1.68
growth rate 2.2% 18.6% -7.8% -3.3% -7.4% 48.9% -3.9% 5.1% -8.7% -10.6%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 23.20
33.30
36.90
54.28
68.82
93.46
132.31
160.50
172.20
181.20
growth rate 43.5% 10.8% 47.1% 26.8% 35.8% 41.6% 21.3% 7.3% 5.2%
Acct.Payable 52.27
57.81
72.75
9.41
10.80
9.50
10.60
growth rate 10.6% 25.9% -87.1% 14.8% -12.0% 11.6%
Cur.Assets 123.80
126.40
163.70
183.14
274.18
178.66
258.62
320.30
343.20
381.40
growth rate 2.1% 29.5% 11.9% 49.7% -34.8% 44.8% 23.9% 7.2% 11.1%
Total Assets 169.60
211.10
261.20
348.79
428.45
796.40
930.62
1,118.70
1,189.20
1,332.30
growth rate 24.5% 23.7% 33.5% 22.8% 85.9% 16.9% 20.2% 6.3% 12.0%
Cash 28.90
30.50
35.90
57.78
156.35
68.00
73.79
141.90
147.40
165.10
growth rate 5.5% 17.7% 61.0% 170.6% -56.5% 8.5% 92.3% 3.9% 12.0%
Inventory 0.00 0.00 0.00 0.00 0.00
growth rate
Cur.Liabilities 25.30
37.50
40.60
59.57
66.82
149.76
205.16
193.70
197.90
207.70
growth rate 48.2% 8.3% 46.7% 12.2% 124.1% 37.0% -5.6% 2.2% 5.0%
Liabilities 64.50
83.80
90.40
112.32
116.80
405.09
455.50
575.40
555.90
540.80
growth rate 29.9% 7.9% 24.2% 4.0% 246.8% 12.4% 26.3% -3.4% -2.7%
LT Debt 0.94
8.40
9.00
6.30
0.00
0.00
173.75
158.07
287.40
272.80
252.60
growth rate 798.4% 7.1% -30.0% -100.0% -9.0% 81.8% -5.1% -7.4%
Equity 75.52
105.00
127.30
170.80
236.47
311.65
391.31
475.12
543.30
633.30
791.50
growth rate 39.0% 21.2% 34.2% 38.5% 31.8% 25.6% 21.4% 14.4% 16.6% 25.0%
Common Shares 13.00
35.00
35.00
35.00
36.00
37.00
38.00
37.00
40.00
40.00
41.00
growth rate 169.2% 0.0% 0.0% 2.9% 2.8% 2.7% -2.6% 8.1% 0.0% 2.5%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 3.78
9.30
5.70
15.60
16.70
23.90
38.26
76.10
87.20
69.00
80.10
growth rate 146.0% -38.7% 173.7% 7.0% 43.2% 60.1% 98.9% 14.6% -20.9% 16.1%
Cash Dividends 0.00 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 6.82
21.10
32.30
44.70
60.76
70.21
93.31
149.10
163.80
182.60
241.10
growth rate 209.4% 53.1% 38.4% 35.9% 15.6% 32.9% 59.8% 9.9% 11.5% 32.0%
FCF per Share 0.24
0.18
0.56
0.71
1.14
0.83
0.75
0.62
-0.82
0.84
1.08
growth rate -25.0% 211.1% 26.8% 60.6% -27.2% -9.6% -17.3% -100.0% 100.0% 28.6%
Sale Purchase of Stock 14.10
18.70
31.13
21.00
22.10
16.20
16.50
growth rate 32.7% 66.5% -32.6% 5.2% -26.7% 1.9%
FCF 3.00
6.00
19.00
25.00
36.00
31.00
26.00
20.00
-21.00
24.00
78.00
growth rate 100.0% 216.7% 31.6% 44.0% -13.9% -16.1% -23.1% -100.0% 100.0% 225.0%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 97.62
136.30
188.50
245.50
324.07
422.27
595.00
752.60
924.70
1,082.90
1,220.30
growth rate 39.6% 38.3% 30.2% 32.0% 30.3% 40.9% 26.5% 22.9% 17.1% 12.7%
Op.Income 7.60
17.20
23.60
19.05
18.73
2.59
1.00
-4.10
26.60
89.30
growth rate 126.3% 37.2% -19.3% -1.7% -86.2% -61.5% -100.0% 100.0% 235.7%
IBT 8.40
18.10
23.10
32.88
34.88
2.23
-3.80
18.90
21.00
63.90
growth rate 115.5% 27.6% 42.3% 6.1% -93.6% -100.0% 100.0% 11.1% 204.3%
Net Income 31.60
9.30
12.70
19.05
18.73
2.59
-3.10
14.00
21.00
53.10
growth rate -70.6% 36.6% 50.0% -1.7% -86.2% -100.0% 100.0% 50.0% 152.9%
EPS -0.28
0.91
0.27
0.36
0.53
0.50
0.07
-0.08
0.35
0.52
1.31
growth rate 100.0% -70.3% 33.3% 47.2% -5.7% -86.0% -100.0% 100.0% 48.6% 151.9%
Gross Profit 50.64
76.30
109.50
149.00
201.27
255.39
356.33
383.90
462.50
549.40
648.40
growth rate 50.7% 43.5% 36.1% 35.1% 26.9% 39.5% 7.7% 20.5% 18.8% 18.0%
R&D 10.60
14.30
18.40
23.34
33.79
57.64
82.70
111.00
134.50
170.40
growth rate 34.9% 28.7% 26.9% 44.8% 70.6% 43.5% 34.2% 21.2% 26.7%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 18.60
57.40
47.10
42.60
38.90
growth rate 208.6% -17.9% -9.6% -8.7%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 163.90
181.20
279.80
263.90
247.30
growth rate 10.6% 54.4% -5.7% -6.3%
Acct.Payable 10.70
10.60
8.90
15.10
2.90
growth rate -0.9% -16.0% 69.7% -80.8%
Cur.Assets 329.40
381.40
477.80
548.30
614.40
growth rate 15.8% 25.3% 14.8% 12.1%
Total Assets 1,284.30
1,332.30
1,447.30
1,526.40
1,589.00
growth rate 3.7% 8.6% 5.5% 4.1%
Cash 122.70
165.10
142.00
222.10
303.40
growth rate 34.6% -14.0% 56.4% 36.6%
Inventory
growth rate
Cur.Liabilities 197.50
207.70
176.30
209.00
224.00
growth rate 5.2% -15.1% 18.6% 7.2%
Liabilities 539.20
540.80
473.90
502.50
521.10
growth rate 0.3% -12.4% 6.0% 3.7%
LT Debt 258.10
252.60
247.10
239.70
232.30
growth rate -2.1% -2.2% -3.0% -3.1%
Equity 745.10
791.50
973.40
1,023.90
1,067.90
growth rate 6.2% 23.0% 5.2% 4.3%
Common Shares 0.40
0.40
0.40
0.40
0.40
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 15.80
13.30
16.00
8.80
7.10
growth rate -15.8% 20.3% -45.0% -19.3%
Cash Dividends
growth rate
Cash From OA 88.60
84.50
30.20
117.80
110.30
growth rate -4.6% -64.3% 290.1% -6.4%
Sale Purchase of Stock 4.00
3.10
6.40
4.20
growth rate -22.5% 106.5% -34.4%
FCF 72.80
71.20
14.20
109.00
103.20
growth rate -2.2% -80.1% 667.6% -5.3%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 304.60
329.20
329.40
323.30
329.50
growth rate 8.1% 0.1% -1.9% 1.9%
Op.Income 18.60
57.40
47.10
42.60
38.90
growth rate 208.6% -17.9% -9.6% -8.7%
IBT 17.20
36.30
39.50
40.70
36.40
growth rate 111.1% 8.8% 3.0% -10.6%
Net Income 13.00
31.60
31.10
36.40
26.40
growth rate 143.1% -1.6% 17.0% -27.5%
EPS
growth rate
Gross Profit 160.60
189.50
176.70
170.80
175.10
growth rate 18.0% -6.8% -3.3% 2.5%
R&D 44.80
40.40
48.20
48.40
50.90
growth rate -9.8% 19.3% 0.4% 5.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (89.26)

YOY Growth Grade:

C (66.18)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 43.47 42.68 27.56
EPS / Growth 18.1% 3.06 30.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 22.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 18.1% 23.7% 23.7%
Future PE 27.56 39.48 39.48
Future EPS 16.08 25.66 25.66
Value Price
MOS %
109.52
-16.0%
250.40
92.0%
250.40
92.0%
MOS Price 54.76 125.20 125.20
IRT 12.15 10.39 10.39

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.